Export 152 results:[ Author] Title Type Year
Filters: First Letter Of Last Name is G [Clear All Filters]
“Developing Materials for Transplant Centers to Share BMT CTN Clinical Trial Results with their Patients: A Pilot Study (Poster).”, in NCI ASCO Cancer Trials Accrual Symposium, Bethesda, MD, 2010.,
“Lessons from IAVI-006, a phase I clinical trial to evaluate the safety and immunogenicity of the pTHr.HIVA DNA and MVA.HIVA vaccines in a prime-boost strategy to induce HIV-1 specific T-cell responses in healthy volunteers.”, Vaccine, vol. 26, no. 51, pp. 6671-7, 2008.,
“Priming with a candidate HIV-1 clade A DNA vaccine followed by boosting with an HIV-1 Clade A MVA vaccine in volunteers at low risk of HIV infection”, 2004.,
“Loss to Follow-Up from HIV Screening to ART Initiation in Rural China.”, PLoS One, vol. 11, no. 10, p. e0164346, 2016.,
“A Phase I Randomized, Double-blind, Single Subcutaneous Dose Escalation Study to Determine the Safety, Tolerability, and Pharmacokinetics of Rezafungin in Healthy Adult Subjects”, Clin Transl Sci, vol. 15, no. 7, pp. 1592-1598, 2022.,
“Validation of the TAPS-1: A Four-Item Screening Tool to Identify Unhealthy Substance Use in Primary Care.”, J Gen Intern Med, vol. 32, no. 9, pp. 990-996, 2017.,
“SCORE Study Report 5: A randomized trial comparing the efficacy and safety of intravitreal triamcinolone with observation to treat vision loss associated with macular edema secondary to central retinal vein occlusion: the Standard Care vs Corticosteroid f”, Archives of Ophthalmology, vol. 127, pp. 1101-1114, 2009.,
“The Age-Related Eye Disease Study (AREDS): design implications. AREDS report no. 1.”, Control Clin Trials, vol. 20, no. 6, pp. 573-600, 1999.
“The effect of five-year zinc supplementation on serum zinc, serum cholesterol and hematocrit in persons randomly assigned to treatment group in the age-related eye disease study: AREDS Report No. 7.”, J Nutr, vol. 132, no. 4, pp. 697-702, 2002.
“Secondary analyses of the effects of lutein/zeaxanthin on age-related macular degeneration progression: AREDS2 report No. 3.”, JAMA Ophthalmol, vol. 132, no. 2, pp. 142-9, 2014.,
“The Relationship of Dietary Carotenoid and Vitamin A, E, and C Intake with Age-Related Macular Degeneration in a Case-Control Study: AREDS Report No. 22”, Arch Ophthalmol, vol. 125, pp. 1225-1232, 2007.,
“Risk factors associated with age-related macular degeneration. A case-control study in the Age-Related Eye Disease Study: Age-Related Eye Disease Study Report No. 3”, Ophthalmology, vol. 107, pp. 2224-32, 2000.,
“Impact of antioxidants, zinc, and copper on cognition in the elderly. A randomized, controlled trial. AREDS Report No. 12”, Neurology, vol. 63, pp. 1705-1707, 2004.,
“The relationship of dietary carotenoid and vitamin A, E, and C intake with age-related macular degeneration in a case-control study: AREDS Report No. 22.”, Arch Ophthalmol, vol. 125, no. 9, pp. 1225-32, 2007.,
“National Eye Institute Visual Function Questionnaire in the Age-Related Eye Disease Study (AREDS). AREDS Report No. 10”, Arch Ophthalmol, vol. 121, pp. 211-217, 2003.,
“Baseline nutritional status of AREDS participants, Poster presentation by AREDS participants”, Experimental Biology, 1999.,
“A randomized, placebo-controlled, clinical trial of high-dose supplementation with vitamins C and E and beta carotene for age-related cataract and vision loss: AREDS report no. 9.”, Arch Ophthalmol, vol. 119, no. 10, pp. 1439-52, 2001.
“Associations of mortality with ocular disorders and an intervention of high-dose antioxidants and zinc in the Age-Related Eye Disease Study. AREDS Report No. 13”, Archives of Ophthalmology, vol. 122, pp. 716-726, 2004.,
“Visual Acuity After Cataract Surgery in Patients with Age-Related Macular Degeneration: Age-Related Eye Disease Study 2 Report Number 5”, Ophthalmology, vol. 121, pp. 1229-1236, 2014.,